Stocks and Investing Stocks and Investing
Thu, January 21, 2021
[ 12:00 AM ] - WOPRAI
Ammar Samma Maintained (SMBK) at Buy with Increased Target to $22 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (SM) at Buy with Increased Target to $11 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Kyle Joseph Upgraded (BBDC) to Strong Buy and Increased Target to $11 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Cai Rumohr Maintained (TXT) at Hold and Held Target at $46 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Paul Trussell Upgraded (UAA) to Strong Buy and Increased Target to $22 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Ryan Gee Downgraded (U) to Sell on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (THC) at Strong Buy with Increased Target to $60 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Giacomo Romeo Initiated (XOM) at Sell on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Richard Davis Maintained (UPLD) at Strong Buy with Increased Target to $57 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (ULTA) at Buy with Increased Target to $330 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
George Hill Maintained (UNH) at Strong Buy with Increased Target to $409 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (APA) at Buy with Increased Target to $21 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Shahriar Pourreza Downgraded (ALE) to Hold and Held Target at $66 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (AG) at Strong Buy and Held Target at $16 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Robert Spingarn Downgraded (TGI) to Hold and Held Target at $14 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Sam Margolin Upgraded (TELL) to Buy and Held Target at $5 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Shahriar Pourreza Upgraded (AEP) to Strong Buy and Held Target at $93 on, Jan 21st, 2021
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (WNS) at Strong Buy with Increased Target to $85 on, Jan 21st, 2021
Wed, January 20, 2021
[ 12:00 AM ] - WOPRAI
Simeon Gutman Upgraded (WSM) to Hold on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Bouley Maintained (WMS) at Buy with Increased Target to $98 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Gabriel Moreen Maintained (WMB) at Strong Buy with Increased Target to $26 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Ken Usdin Maintained (WFC) at Strong Buy with Decreased Target to $37 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Joseph DeNardi Maintained (AAL) at Hold with Increased Target to $14 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Robert Driscoll Initiated (ZNTL) at Buy and Held Target at $65 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
David Long Maintained (ZION) at Strong Buy with Increased Target to $61 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Erik Suppiger Initiated (ZS) at Buy and Held Target at $255 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AES) at Buy with Increased Target to $30 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Decreased Target to $79 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Decreased Target to $99 on, Jan 20th, 2021
[ 12:00 AM ] - WOPRAI
Thomas Smith Maintained (ACRS) at Buy with Increased Target to $21 on, Jan 20th, 2021

Thomas Smith Maintained (ACRS) at Buy with Increased Target to $21 on, Jan 20th, 2021


Published on 2024-10-27 15:18:12 - WOPRAI, Thomas Smith
  Print publication without navigation


Thomas Smith of SVB Leerink, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Increased Target from $4.5 to $21 on, Jan 20th, 2021.

Thomas, nor any peers, have made any analyst calls on ACRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources